Latest Cost Management News

4DMedical Limited’s half-year report reveals rapid commercial traction following FDA clearance of its CT:VQ™ imaging technology, alongside a $150 million institutional placement that bolsters its cash reserves for global expansion.

WT Financial Group has reported robust half-year results for H1 FY2026, marked by a 20.8% increase in underlying net profit after tax and a fully franked interim dividend. The company’s strategic pivot to a business-to-business advice model and its Investco joint venture underpin its growth trajectory.

MOVE Logistics Group reports a 98% improvement in normalised earnings before tax and a significant reduction in net debt, positioning the company on track for a profitable FY26 despite ongoing market challenges.

DorsaVi Limited reported a steep increase in its half-year loss to $3.6 million, driven by declining revenues and a sharp rise in operating costs, despite raising over $5 million in fresh capital.

Dubber Corporation reported a 9% revenue decline to $18.7 million for the half-year ending December 2025, alongside a 65% reduction in net loss. The company pursues growth through AI innovation and cost efficiencies while navigating ongoing legal proceedings.

BrainChip Holdings Ltd reported a striking 374% jump in revenue for 2025, yet the company still posted a substantial operating loss of over US$20 million. The results reveal mixed signals for investors watching the semiconductor innovator’s path forward.

Beonic Limited reported a 5.5% revenue increase to $11.2 million and reduced its net loss to $1.44 million for the half-year ending December 2025. The company also repaid a $4.65 million loan and secured a major $7.3 million contract to deploy passenger flow management solutions across seven Moroccan airports.

Advanced Braking Technology Ltd has corrected its half-year results to reveal a robust 55.2% increase in earnings per share, alongside a strong 27% revenue growth driven by demand for its safety braking systems.

Vectus Biosystems reports a narrowed half-year loss as it advances clinical drug VB0004 and nears a key asset sale to XORTX Therapeutics.

IDP Education reported a 6% revenue decline in H1 FY26 but outperformed volume drops through yield improvements, upgrading its full-year EBIT guidance. The company is on track to deliver $25 million in cost savings, driven by operational efficiencies and technology investments.

Capral Limited reported a resilient FY25 with earnings growth despite market headwinds, declaring a 30-cent dividend and reinforcing its commitment to sustainability with a 20% emissions reduction target by 2030.

Australian Ethical Investment Limited has reported a robust half-year performance, with profits and funds under management hitting new highs, underpinned by strategic platform upgrades and sustained net inflows.